pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
NG-350A
Epithelial Tumor
Akamis Bio Ltd
0
catalysts
Phase 1
NKT-3964
Adenocarcinoma Of The Gastroesophageal Junction
NiKang Therapeutics Inc
0
catalysts
Phase 1
NM-6603
Colorectal Cancer
Nucmito
0
catalysts
Phase 1
NMS-812
Refractory Acute Myeloid Leukemia
← prev
page 28 of 62
next →
131
Pain
89
Neurology
1
Nerviano Medical Sciences SRL
0
catalysts
Phase 1
NN-3201
Adenoid Cystic Carcinoma (ACC)
Novelty Nobility Inc
0
catalysts
Preclinical
NOD-2
Unspecified Cancer
Nodus Oncology Ltd
0
catalysts
Phase 2
NOUS-209
Gastric Cancer
Nouscom AG
0
catalysts
Preclinical
NOVS-100
Obesity
Celloram Inc
0
catalysts
Preclinical
NP-855
Neuroblastoma
NanoPharmaceuticals LLC
0
catalysts
Phase 3
NPG-2044
Ovarian Cancer
Novita Pharmaceuticals Inc
0
catalysts
Phase 1
NPX-887
Adenocarcinoma Of The Gastroesophageal Junction
NextPoint Therapeutics Inc
0
catalysts
Phase 2
NT-219
Metastatic Colorectal Cancer
$PPBT
PURPLE BIOTECH LTD.
0
catalysts
Phase 3
NTO-1151
Triapine
Cervical Cancer
Ribonucleotide reductase
Resilience Government Services Inc
0
catalysts
Phase 2
NTX-301
Chronic Myelomonocytic Leukemia (CMML)
Pinotbio Inc
0
catalysts
Preclinical
NU-001
Ovarian Cancer
NUAgo Therapeutics Inc
0
catalysts
phase_0
NU-0129
Gliosarcoma
Northwestern University
0
catalysts
Preclinical
NV-101
Ewing Sarcoma
Oncology Pharma Inc
0
catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0
catalysts
Phase 1
NX-1607
Adenocarcinoma Of The Gastroesophageal Junction
$NRIX
Nurix Therapeutics, Inc.
0
catalysts
Phase 1
NXP-900
Cervical Cancer
$NVCT
Nuvectis Pharma, Inc.
0
catalysts
Preclinical
Nanoapalutamide
Prostate Cancer
Nanoform Finland Plc
0
catalysts
Preclinical
Nanoparticle Mesothelin MOTO-CAR
Solid Tumor
Thunder Biotech Inc
0
catalysts
Phase 2
Nerofe
Refractory Acute Myeloid Leukemia
Immune System Key Ltd
0
catalysts
Preclinical
Next-generation CAR-T
Ovarian Cancer
ToolGen Inc
0
catalysts
Preclinical
No Alpha IL-2 Mutein
Unspecified Cancer
Roswell Park Cancer Institute
0
catalysts
Preclinical
Novel Molecules for Glioma
Glioma
$MRK
Merck & Co., Inc.
0
catalysts
Preclinical
Novel Therapeutic
Glioblastoma Multiforme (GBM)
Rosalind Franklin University of Medicine and Science
0
catalysts
Phase 2
OBI-902
Bile Duct Cancer (Cholangiocarcinoma)
OBI Pharma Inc
0
catalysts
Phase 2
OBX-115
Metastatic Melanoma
Obsidian Therapeutics Inc
0
catalysts
Preclinical
OCX-410
Non-Small Cell Lung Carcinoma
$OCEA
Ocean Biomedical, Inc.
0
catalysts
